Increased incidence of hepatocellular carcinoma in Western countries: The reasons and the consequences;Augmentation de l'incidence du carcinome hepatocellulaire dans les pays occidentaux. Quelles raisons et quelles consequences?

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 12, 1999, Pages 1286-1288

  Trinchet, Jean Claude ^a   Beaugrand, Michel ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Alcohol; Epidemiology; Hepatitis C virus; Hepatocellular carcinoma; Incidence

Indexed keywords

ALCOHOLISM; CANCER INCIDENCE; CANCER MORTALITY; CHRONIC HEPATITIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PUBLIC HEALTH; REVIEW;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; PUBLIC HEALTH;

EID: 0033374742     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Chevret S, Trinchet JC, Mathieu M, Abou Rached A, Beaugrand M, Chastang C, et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999;31:133-41.
2. Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997;25:259-62.
3. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997;27:756-65.
4. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142-3.
5. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998;351:214-5.
6. De Vos-Irvine HD, Goldberg D, Hole DJ, McMenamin J. Trends in primary liver cancer. Lancet 1998;351:215-6.
7. El-Serag H, Mason A. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
8. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998;29:944-52.
9. Poynard T, Bedossa P, Opolon P, OBSVIRC, METAVIR, CLINIVIR, et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
10. Haut Comité de la Santé Publique. La santé en France. Rapport général, Paris : La Documentation Française ; 1994.
11. Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999;29:1596-601.
12. Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23: 1112-8.
13. Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Zhang YJ, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996;24:38-42.
14. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999;30:956-61.
15. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
16. Roudot-Thoraval F, Bastie A, Dhumeaux D, Epidémiologie des infections liées au virus de l'hépatite C : évolution récente, perspectives. Hépato-Gastro 1999;6:101-6.
17. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
18. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-7.
19. Ganne-Carrié N, Christidis C, Beaugrand M. Vers une chimio-prévention du carcinome hépatocellulaire ? Gastroenterol Clin Biol 1997;21:447-9.